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 Abstract  
 
Objective: The objective of this selective EBM review is to determine whether or not “Does 
cognitive therapy reduce symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in 
patients older than 12 years old who are diagnosed with ADHD?” 
 
Study Design: Systematic review of three randomized controlled trials (RCTs) published in 
peer-reviewed journals in 2016, all English language 
 
Data Sources: Three randomized controlled trials were found using PubMed.  
 
Outcomes Measured: ADHD symptoms and patients’ response to cognitive therapy were 
measured by patients, parents of patients, and independent evaluators with Disruptive Behavior 
Disorder rating scales that included four scales of the Diagnostic and Statistical Manual for 
Mental Disorders 4th edition including (1) ADHD Inattention, (2) ADHD 
Hyperactivity/impulsivity, (3) Oppositional Defiant Disorder, and (4) Conduct Disorder.  
 
Results: Boyer et al found no significant differences between groups receiving PML and SFT; 
instead, they found that patients with more ADHD symptoms benefited more from PML while 
patients with less ADHD symptoms benefited more from SFT. Spirch et al found a statistically 
significant reduction in parent-rated, patient-rated ADHD symptoms scores and evaluator-rated 
CGI scores for participants who received cognitive behavior therapy as opposed to the waitlisted 
group. Likewise, Young et al also found a statistically significant and precise reduction and 
difference in ADHD symptoms scores between an experimental group receiving CBT and an 
experimental group continuing with TAU.  
 
Conclusions: All three Randomized Controlled Trials indicate that CBT is effective in treatment 
of ADHD in patients >12 years old by reducing symptoms of impulsivity, hyperactivity, and 
inattention as outline in the DSM-IV criteria.  
 
Key Words: cognitive therapy, behavioral therapy, Attention Deficit Hyperactivity Disorder  
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Introduction   
Attention Deficit Hyperactivity Disorder (ADHD) is a neurocognitive disorder that 
presents during childhood development and is associated with symptoms of impulsivity, 
inattention, and hyperactivity.1 ADHD is common, affecting 7-8% of children and 2.5% of 
adults.1 Furthermore, 65% of patients diagnosed with ADHD during childhood will continue to 
meet the criteria for diagnosis through adolescent life.2 ADHD is often comorbid with other 
psychiatric and mental disorders, leading to impairment in social, academic, and occupational 
settings.3 The cost of ADHD in the United States ranges between $143 billion-$266 billion and is 
mostly incurred by education and healthcare expenses. The healthcare costs per American patient 
0-21 years old can range $621-$2,270 annually.3 In January 2017, the CDC reported a total visit 
rate of 105 out of 1000 persons in one year.4 A Physician Assistant could be directly involved in 
the care for a patient with ADHD, as it is a common condition among patients. 
ADHD is categorized based on the symptoms a patient most commonly experiences. 
Typically, it is thought that features of hyperactivity and impulsivity are manifested together so 
patients exhibit and experience feelings of inner restlessness, impatience, or the desire to be “on 
the go”.5 Patients with ADHD that is predominantly inattentive will be disorganized, distracted, 
or have difficulty focusing.5 In either instance, ADHD is a disease that has the potential to impair 
a patient’s functional ability to carry out advanced Activities of Daily Living (ADL). It is known 
that ADHD is related to multi-gene mutations and common genetic disorders such as fragile X, 
Turner, and Klinefelter syndromes. Though it is often associated with genetic abnormalities, the 
exact etiology of the disease is unknown and often considered to be multifactorial.1   
Currently, Cognitive Behavioral Therapy (CBT) is the first line treatment for ADHD 
because of the conservative means to control symptoms. Often, this diagnosis is made during 
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childhood, so there is a desire to initially attempt modalities other than pharmacologic measures 
such as environmental modification and behavioral training.1 As patients grow older, they could 
still be affected by similar ADHD symptoms they experienced as a child, and it is important to 
study the effects of CBT in an older population. Supplemental pharmacologic therapies include 
stimulant medications such as methylphenidate and mixed amphetamine.1 Other alternative 
medications include clonidine, guanfacine, and atomoxetins.1 While there are medical treatment 
modalities for ADHD, this paper evaluates three randomized controlled trials comparing the 
efficacy of CBT as opposed to pharmacotherapy.  
Objective  
The objective of this selective EBM review is to determine whether or not “Does 
Cognitive Behavioral Therapy (CBT) reduce symptoms of Attention Deficit Hyperactivity 
Disorder (ADHD) in patients older than 12 years old who are diagnosed with ADHD?”  
Methods  
 Three Randomized Controlled Trials (RCTs), including male and female participants 
greater than 12 years old who were diagnosed with ADHD, were selected for this study. Patients 
included in the participant pool were required to be previously diagnosed with ADHD by a 
primary care provider using criteria found in Diagnostic and Statistical Manual of Mental 
Disorders (DSM). During the course of the three trials, participants had the potential to be 
selected for CBT so that ADHD-related symptoms and patient function could be monitored. The 
basis of this review is to understand if CBT can reduce symptoms of ADHD in adolescents and 
adults. CBT is the primary intervention used in all three studies, and therapy programs were 
designed by the authors of each study. Areas of focus included planning, problem solving, 
reasoning, rehabilitation, and functional impairment reduction. In order to measure the effects of 
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therapy, parent-interviews, patient-interviews, and independent evaluators were utilized to 
quantify and qualify results. For this review, the outcomes measured were compared with pre-
trial assessments of each participant’s symptom-related and function-related scores and further 
compared to control groups. Patient outcomes were also measured against control groups, 
comprised of participants who were receiving different kinds of CBT, their Treatment as Usual 
(TAU), or no intervention for ADHD-related symptoms. Patient outcomes were measured based 
on DSM-IV criteria scales for ADHD inattention, ADHD hyperactivity/impulsivity, 
Oppositional Defiant Disorder, and Conduct Disorder. In addition, scaled criteria for factors 
related to function and ADLs were differentiated in subscales including ADHD symptoms, 
emotional control, antisocial behavior, and social functioning.  
Each study evaluated in this review was a RCT found in the PubMed database by 
searching key-words such as cognitive therapy and Attention Deficit Hyperactivity Disorder. All 
studies were published in the English language in peer-review journal articles in 2016. The 
author completed all research for this review and selected articles based on relevance to the topic 
and if the outcomes measures were patient-oriented. In order for these studies to be applicable to 
this review, inclusion criteria included RCTs studying patient-oriented outcomes after receiving 
CBT for ADHD. Studies were excluded from the review if they contained criteria such as 
participants under 12 years old, patients with suicidal ideation, patients with organic mental 
disability or autism spectrum disorders. Statistical means by which studies were analyzed include 
F, ωp2, p, NNT, Coef. (β), and a study-developed method called QUINT.  
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Table 1: Demographics & Characteristics of Included Studies  
Study  Type  # Pts  Age 
(years)  
Inclusion 
Criteria  
Exclusion 
Criteria  
W/D Interventions  
Boyer2, 
2016 
RCT 159 12-17  -adolescents 12-
17 years old 
-attend 
secondary 
school 
-diagnosis with 
ADHD with 
DSM-IV criteria 
-IQ >80 
-autism spectrum 
disorder 
-depression with 
suicidal ideation 
-familial crisis 
-Crohn’s  
-addiction 
44 Planning focused 
cognitive therapy 
(PML) & 
Solution focused 
cognitive therapy 
(SFT) 
Spirch6, 
2016 
RCT 46 14-18  -adolescents 14-
18 years old 
-ADHD with 
CGI >3  
-on stable dose 
of FDA 
approved 
medications for 
ADHD 
-no change in 
dose for at least 
2 months 
-comorbid 
disorders 
-suicidality 
-conduct 
disorder  
-active substance 
abuse or 
dependence 
-mental disorder  
-mental 
retardation  
-pervasive 
developmental 
disorder  
-history of CBT 
for ADHD 
10 Therapy modules 
including:  
Psycho-education 
& organized 
planning, 
distractibility, 
adaptive 
thinking, 
procrastination, 
parent-adolescent 
sessions, parent-
only sessions, 
relapse 
prevention  
Young7, 
2016 
RCT 95 >18  ->18 years old 
-diagnosis of 
ADHD 
-self-reported 
stability on 
prescribed 
ADHD 
medication for 
>1 month   
-mental illness  
-suicidal ideation  
-eating disorder  
-drug abuse  
-intellectual 
impairment  
39 Revision of 
Reasoning and 
Rehabilitation 
pro social 
competence 
training program  
Outcomes Measured  
 The outcomes measured in the selected studies were based on subjective scores of ADHD 
symptoms from the perspectives of patients, parents, and third party independent evaluators and 
were centered on patient-oriented outcomes.  
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 Boyer et al measured ADHD symptoms from four scores of the Disruptive Behavior 
Disorder (DBD) rating scale, which included (1) ADHD Inattention, (2) ADHD 
Hyperactivity/impulsivity, (3) Oppositional Defiant Disorder, and (4) Conduct Disorder, based 
on DSM-IV criteria.2 In this study, planning problems were evaluated using the Behavior Rating 
Inventory of Executive Functioning and the Planning/Organizing Scale. Outcomes were 
measured via parent-reporting at a pre-test period (one week before intervention), a post-test 
period (one week after intervention), and a maintenance period (three months after intervention).  
 Spirch et al measured outcomes using the results of an independent evaluator ADHD 
severity rating scale based on DSM-IV criteria for ADHD-symptoms.6 Scores ranged from 0-3; a 
score of zero indicated that the symptom was not present while three indicated that the symptom 
was most severe. Spirch et al also used an independent evaluator Clinical Global Impression 
(CGI) scale which analyzed the severity of the patient’s symptoms ranging from 1 (indicating not 
ill) to 7 (indicating extremely ill). Evaluations were made to identify a patient’s baseline before 
treatment, a post-treatment period (four months after treatment) and a maintenance-period (eight 
months after treatment).  
 Young et al utilized a 32 item participant-reported inventory called RATE-S, which 
encompassed 4 subscales including (1) ADHD symptoms, (2) emotional control, (3) antisocial 
behavior, and (4) social functioning.7 Items were reported on an 8-point scale; a score of zero 
indicated “not at all” while a score of eight indicated “most of the time”. Young et al also 
utilized the CGI scale to quantify the severity of patients’ ADHD symptoms and related 
impairment. The CGI scale was conducted by independent evaluators who were blind to the 
population. Analysis was conducted at the participant’s baseline before intervention was 
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initiated, immediately after treatment was completed as a post-intervention assessment, and a 
follow up score (three months after treatment was ended).  
Results  
QUINT is a method of statistical analysis Boyer et al devised to understand the 
interaction and trajectories of two subgroups – those that received Plan My Life (PML) CBT and 
those that received Solution Focused Treatment (SFT) CBT.2 QUINT is a means to evaluate the 
qualitative outcomes of a total population’s division into optimal subgroups.2 QUINT analysis 
was achieved by separating patients based on pre-test symptom scores and cross-analyzing data 
to better predict what would best benefit patient outcomes. Using QUINT trajectories, Boyer et 
al found that there was no qualitative treatment-subgroup interaction between the pre-test to 
post-test periods.2 Though, QUINT analysis did find that there was a qualitative treatment-
subgroup interaction present during the period between the post-test to 3-month follow up 
period.  
The final analysis of QUINT is shown in Table 2 and revealed that participants who 
began the trial with better symptom-related scores (DBD <24.82) were more likely to benefit 
from SFT over PML treatment methods with a moderate effect size shown by d=0.34. The study 
shows that patients with less ADHD symptoms had an improvement of symptom scores by 2.98 
points when assigned to SFT over PML. Conversely, patients who began with a worse symptom-
related score (DBD >24.82) were more likely to have better responses to the PML treatment than 
the SFT treatment with a moderate effect size shown by d=-0.37. The trial shows that patients 
with more ADHD symptoms had an improvement of symptom scores by 3.29 points when 
assigned to PML over SFT. 
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Table 2: Results of QUINT Analysis Showing Optimal Trajectories of Population Subgroups    
Parent-rated ADHD 
pretest score (DBD) 
QUINT-projected 
benefit 
Score improvement from 
preferential program 
Cohen’s d 
<24.82  Less symptoms  SFT  2.98  0.34  
>24.82 More symptoms  PML  3.29 -0.37 
 
Even though the initial QUINT analysis showed that there would be beneficial responses 
to CBT for participants based on pre-test ADHD symptom scores, ad hoc analysis of the data 
shows that there was actually no statistically significant differences between groups in response 
to treatments, as shown in Table 3.2 Statistical data analysis revealed that there was little 
precision about the outcomes of the data set, exhibited by a p=-0.177 for pre to post test results, 
and p=0.311 for post-test to follow up treatment outcomes. Both ωp2 of 0.006 and 0.000 show a 
small effect size, which means that the responsiveness to treatment was not in strong association 
with specific treatment modalities and the difference in response between groups was minimal.  
Table 3: Precision and Effect Size of Pre-test to Post-test and Post-test to Follow-up Periods     
Time of Evaluation  F  p ωp2 
Pre-test to Post-test  (1,144) = 1.84 -0.177 0.006 
Post-test to Follow up  (1,114) = 1.03   0.311 0.000 
 
Spirch et al held a trial that randomized 46 total participants into a group of 24 
participants who would receive CBT at the start of the study and another group of 22 patients 
who would be placed on a wait list and have treatment delayed for four months after the start of 
the study.6 The study followed a cross-over design in which participants were evaluated within 
their randomly assigned group after the intervention was applied. An intent-to-treat analysis was 
conducted using a linear mixed model and included all available data from those who did or did 
not complete the trial.  
Spirch et al found that there was no significant difference between CGI scores of both 
groups at baseline, shown in Table 4. A reduction of symptoms, shown by the mean in Table 4 
occurs in all groups after the initiation of CBT. This is seen by a reduction of mean score of 4.55 
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at four months post-trial to a mean score of 3.20 mean score at the eight months follow up for the 
waitlisted group. In the experimental group, there is a reduction in mean score from baseline to 
four months post-trial, and again to eight months post-trial, comprising an overall mean score 
reduction of 4.75 to 3.71. These results were found to be statistically significant and precise, 
given the CI and p values reported of 1.17 (1.39, 0.94) and <0.0001, respectively.6  
Table 4: Outcomes of CGI for waitlist (control) and CBT groups  
 Wait List  CBT   
  Mean + SD  Mean + SD 95% CI p value  
Baseline  Baseline  4.64 + 0.85 Baseline  4.75 + 0.68 
1.17  
(1.39, 0.94) <0.0001 
Post-trial  
(4 months) Waitlist 4.55 + 0.80 CBT 3.71 + 0.85 
Follow up 
(8 months) CBT 3.20 + 0.86 CBT 3.71 + 0.96 
	
Parent and adolescent reported scores are shown in Table 5 and mirror the trends seen 
with CGI scores: a statistically significant reduction in symptoms after the initiation of CBT in 
both the experimental and control groups.6 The reductions shown in Table 5 are validated by the 
strong correlation and precision of the CI of 10.93 (12.93, 8.93) and p value of <0.0001.  
Table 5: Outcomes of parent-rated scores and adolescent-rated scores for waitlist (control) and 
CBT (experimental) groups 
  Wait List  CBT   
  Mean + SD Mean + SD 95% CI p value  
Pa
re
nt
 - 
ra
tin
gs
 Baseline  Baseline  
28.05 
+ 9.57 Baseline  
25.30 
+ 9.17 
10.93 
(12.93, 8.93) <0.0001 
Post-trial  
(4 months)  Waitlist  
24.18 
+ 8.23 CBT 
16.76 
+ 10.40 
Follow up 
(8 months) CBT 
12.82 
+ 6.51 CBT 
13.71 
+ 9.65 
A
do
le
sc
en
t -
 
ra
tin
gs
 Baseline  Baseline  
14.41 
+ 8.35 Baseline  
16.46 
+ 10.90 
5.34 
(7.21, 3.28)  <0.0001 
Post-trial  
(4 months) Waitlist  
13.86 
+ 8.12 CBT 
11.95 
+ 8.89 
Follow up 
(8 months) CBT 
7.42 
+ 3.71 CBT 
9.71 
+ 7.21 
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Absolute Benefit Increase and Numbers Needed to Treat (NNT) were also used to 
analyze the efficacy of the trial’s outcomes.6 This trial reveals an especially effective NNT, 
which was calculated to be 4. Though, the study provided data that showed only a 32% increase 
in benefit as a result of the intervention.  
Young et al conducted a study with 95 participants (N=90) that were randomized into a 
control group containing 47 participants (N=47) and an experimental group of 48 participants 
(N=48).7 All participants of the controlled trial were analyzed in the group they were randomly 
assigned. An intent-to-treat analysis was conducted. Data was analyzed using a linear mixed 
model while controlling for age as a variable.  
Outcomes of ADHD-related symptoms and CGI scores at baseline showed no statistically 
significant difference in scores between the experimental group that received CBT and the 
control group who maintained treatment as usual, as shown in Table 6. Table 6 also shows a 
steady reduction in both RATE-S and CGI scores for the experimental group depicted by an 
overall reduction in mean score of 41.76 to 29.28 for RATE-S and 3.96 to 3.14 for CGI. Though, 
the patients who resumed TAU showed no or minimal reduction in these scores throughout the 
progression of the trial, as seen by comparing RATE-S score at baseline (40.39) to follow up 
(38.66) or CGI score at baseline (3.91) to follow up (3.80).  
Table 6: Outcomes measured by RATE-S Scores and Clinical Global Impression Scores at 
baseline, end of treatment, and follow up 
 CBT (Mean + SD) TAU (Mean + SD) 
 Baseline 
Mean  
End of 
Treatment Mean  
Follow 
up Mean 
Baseline 
mean  
End of 
Treatment Mean  
Follow 
up Mean 
RATE-S  41.76 + 11.05  
34.30 
+ 10.30 
29.28 
+ 11.47  
40.39 
+ 11.56 
38.77 
+ 11.56 
38.66 
+ 11.93  
CGI  3.96 + 0.81 
3.03 
+ 1.05 
3.14 
+ 0.79 
3.91 
+ 1.10  
3.79 
+ 0.77 
3.80 
+ 0.96 
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Young et al compared baseline scores to the end-of-treatment scores and also made 
comparisons between end-of-treatment scores and the follow-up scores.7 Both comparisons show 
a reduction in ADHD symptoms for participants receiving CBT. Table 7 indicates the highly 
significant reducing trends with highly precise estimates for RATE-S outcomes in patients, as 
noted by the significant p values of <0.05. The criteria of ADHD-symptoms and social 
functioning, noted by large Coef (β) calculations of -5.4 and -5.31, respectively shows that these 
variables strongly influenced the outcome of improving ADHD symptoms and ADLs of patients 
with ADHD. The largest effect sizes were noted in the ADHD symptoms and antisocial 
behavior, noted by the large effect sizes, d= 0.55 and 0.50, respectively. Overall, Young et al 
found that participants who received CBT showed a greater reduction in symptoms and 
functional scores than those participants who were in the TAU group.7  
Table 7: Estimated treatment effect for Rate-S symptoms  
RATE-S Outcome Coef (β)  Standard error  P value  95% CI Effect Size (d)  
ADHD symptoms  -5.64 1.58 <0.001 (-8.75, -2.53) 0.55 
Social functioning  -5.31 1.48 <0.001 (-8.21, -2.41)  0.41 
 
Patients who had previously received a formal diagnosis of ADHD met with evaluators 
and cognitive behavioral therapy coaches in an outpatient setting. No study reported any adverse 
events associated with receiving CBT.  
Discussion  
 Cognitive Behavioral Therapy is an emerging treatment for psychological and 
psychosocial disorders in the United States. As a supplemental treatment, there is no harm or 
contraindications to engaging in CBT. CBT is a treatment modality that combines the techniques 
of cognitive and developmental therapies and theories of human behavior.7 In the literature, CBT 
has been utilized to aid in the treatment of multiple psychological and neurocognitive disorders. 
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For example, CBT has been studied to be a supplemental treatment of borderline personality 
disorder, schizophrenia, obsessive compulsive disorder, post-traumatic stress disorder, eating 
disorders, and addictive disorders.7 Because CBT is a developing modality of treatment, there is 
much that needs to be studied in relation to CBT and efficacy. The selected studies were limited 
mostly by the ability to blind participants from treatment groups. Patients and parents were 
aware of the which participants received CBT and represented a potential source for bias in 
reported results. Though a relatively new method of treatment, CBT is recommended as first-line 
for treatment of psychosocial disorders, especially ADHD.  
Conclusion  
The results of these studies shows that CBT is effective in reducing the symptoms of 
ADHD and aids in the functional improvement of ADLs. Though, further studies should be 
conducted to overcome some of the barriers that these trials faced. For example, these studies did 
not address the differences in which pre-trial ADHD symptoms predominated in patients and 
thus did not consider how this would factor into response to CBT. Further studies could assess 
the response to CBT in patients with ADHD and separate data for 3 patient populations where 
ADHD symptoms are predominantly (1) hyperactive, (2) inattentive, or (3) impulsive. The study 
could then measure how these three ADHD-subgroups respond to treatment and ensure that 
cognitive behavioral therapy could be universally utilized as treatment. In addition, these studies 
utilized patient and parent-based scores to determine the efficacy of the treatments, even though 
patients and parents were not blind to treatment. This factor is a potential source for bias in the 
study; thus, possibly influencing the outcome measurements of the effectiveness of the therapy. 
Further research should better utilize independent evaluators as the means for analysis.  
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